Literature DB >> 16731294

Predictors of outcome in Henoch-Schönlein nephritis in children and adults.

Rosanna Coppo1, Simeone Andrulli, Alessandro Amore, Bruno Gianoglio, Giovanni Conti, Licia Peruzzi, Francesco Locatelli, Leonardo Cagnoli.   

Abstract

BACKGROUND: Factors predictive of renal outcome were investigated in 219 cases of biopsy-proven Henoch-Schönlein purpura nephritis (HSPN); 83 children and 136 adults enrolled in a national study were followed up for up to 27 years (median, 4.5 years).
METHODS: The criterion for defining disease progression was time elapsed until doubling of baseline creatinine level and until dialysis therapy. Age, sex, data at onset (renal function, proteinuria, hematuria, hypertension, and crescents), and data during follow-up (proteinuria and therapy) were tested as covariates.
RESULTS: Multivariate Cox regression analysis indicated the following parameters as independent prognostic predictors: age (adults versus children, relative risk, 3.57; 95% confidence interval, 1.18 to 10.79; P = 0.024 for creatinine level doubling; relative risk, 14.89; 95% confidence interval, 1.72 to 129.07; P = 0.014 for dialysis therapy), sex (females versus males, relative risk, 5.71; 95% confidence interval, 1.67 to 19.55; P = 0.006 for creatinine level doubling; relative risk, 26.03; 95% confidence interval, 2.64 to 256.73; P = 0.005 for dialysis therapy), and mean proteinuria during follow-up (for each 1 g/d of protein increase, relative risk, 1.77; 95% confidence interval, 1.35 to 2.32; P < 0.001 for creatinine level doubling; relative risk, 1.73; 95% confidence interval, 1.18 to 2.52; P = 0.005 for dialysis therapy). Information for mean proteinuria levels during follow-up increased the sensitivity at logistic regression to 62.5%, with dialysis therapy as the end point. No data detected at diagnosis, including renal function impairment, proteinuria, hypertension, and crescentic nephritis (involving > 50% of glomeruli in only 2.6%), were significantly related to functional decline at multivariate Cox.
CONCLUSION: This analysis indicates that, even more than when decreased renal function, severe proteinuria, hypertension, or crescents are present at onset, the risk for progression of HSPN (greater in adults and females) was associated with increasing mean proteinuria levels during follow-up.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731294     DOI: 10.1053/j.ajkd.2006.02.178

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  57 in total

1.  Outcome of Henoch-Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset.

Authors:  Outi Jauhola; Jaana Ronkainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Örmälä; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2012-02-05       Impact factor: 3.714

2.  The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schönlein purpura nephritis.

Authors:  Mikael Koskela; Elisa Ylinen; Elli-Maija Ukonmaanaho; Helena Autio-Harmainen; Päivi Heikkilä; Jouko Lohi; Outi Jauhola; Jaana Ronkainen; Timo Jahnukainen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2017-02-14       Impact factor: 3.714

3.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

4.  Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.

Authors:  Ke Xu; Lili Zhang; Jie Ding; Suxia Wang; Baige Su; Huijie Xiao; Fang Wang; Xuhui Zhong; Yanming Li
Journal:  J Nephrol       Date:  2017-11-28       Impact factor: 3.902

5.  Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity.

Authors:  Takeshi Ninchoji; Hiroshi Kaito; Kandai Nozu; Yuya Hashimura; Kyoko Kanda; Ichiro Kamioka; Yuko Shima; Kiyoshi Hamahira; Koichi Nakanishi; Ryojiro Tanaka; Norishige Yoshikawa; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

6.  Histological prognostic factors in children with Henoch-Schönlein purpura nephritis.

Authors:  Jean-Daniel Delbet; Guillaume Geslain; Martin Auger; Julien Hogan; Rémi Salomon; Michel Peuchmaur; Georges Deschênes; David Buob; Cyrielle Parmentier; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2019-11-06       Impact factor: 3.714

7.  Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura.

Authors:  Joyce P Samuel; Cynthia S Bell; Donald A Molony; Michael C Braun
Journal:  Clin J Am Soc Nephrol       Date:  2011-06-23       Impact factor: 8.237

Review 8.  How have the past 5 years of research changed clinical practice in paediatric nephrology?

Authors:  Stephen D Marks
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

Review 9.  Primary disease recurrence—effects on paediatric renal transplantation outcomes.

Authors:  Justine Bacchetta; Pierre Cochat
Journal:  Nat Rev Nephrol       Date:  2015-04-28       Impact factor: 28.314

Review 10.  Pathogenesis of Henoch-Schönlein purpura nephritis.

Authors:  Keith K Lau; Hitoshi Suzuki; Jan Novak; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2009-06-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.